On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression

Abstract

Results from a recent Phase II trial of psilocybin-assisted therapy for treatment-resistant depression suggest modest efficacy but raise concerns about potential for serious adverse effects. The study highlights the need for rigorous assessment of blinding integrity, expectancy, and further study of factors that may contribute to risk in vulnerable populations.

Stay Updated On Psychedelic News

Join our newsletter to receive updates about the latest psychedelic news, hear about our ground-breaking research, and learn what we think about the latest trends shaping the future of psychedelics.

Planning Your Psychedelic Trip?
Our Info Line Can Help.

We provide 100% free, 1:1 guidance for anyone preparing for a psychedelic experience. Learn more about our evidence-based approach or book a call today.

Learn MoreBook a Call

Subscribe for Access and Updates

Join our email list and get immediate access to our psilocybin and ayahuasca guides. You’ll also get the latest in how we’re bridging the gap between science and soul: psychedelic research updates, real-world findings, community-driven education, personal stories and expert insights on natural medicine.

Get Free Access To Our Psilocybin And Ayahuasca Guides

Unlimited Sciences

Advancing Real-World Psychedelic Research and Science-Backed Education

Unlimited Sciences is provided a nonprofit status by fiscal sponsorship through Realm of Caring Foundation.

Federal EIN: 46-3371348.

© 2025 Unlimited Sciences. All Rights Reserved.

Designed by Gloss